NCT03586414View on ClinicalTrials.gov

MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women

NAActive, not recruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

July 31, 2030

Study Completion Date

August 31, 2030

Conditions
Diastolic Dysfunction
Interventions
DIETARY_SUPPLEMENT

MITOQUINOL MESYLATE then placebo

MITOQUINOL MESYLATE then placebo: 'MITOQUINOL MESYLATE' administered twice daily for 4 weeks followed by a washout, then placebo capsule administered twice daily for 4 weeks. Capsules with active product contain 20 mg of 'MITOQUINOL MESYLATE'.

DIETARY_SUPPLEMENT

Placebo, then MITOQUINOL MESYLATE

'Placebo, then MITOQUINOL MESYLATE' : Placebo administered twice daily for 4 weeks followed by a washout, then 'MITOQUINOL MESYLATE' capsule administered twice daily for 4 weeks. Capsules with active product contain 20 mg of 'MITOQUINOL MESYLATE'.

Trial Locations (1)

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

University of Colorado Nutrition Obesity Research Center (NORC)

UNKNOWN

lead

University of Colorado, Denver

OTHER